Orkambi & Infective pulmonary exacerbation of cystic fibrosis
14.4%
of users reported Infective pulmonary exacerbation of cystic fibrosis
97.0%
also reported Hospitalization
54.0%
are women
Most common medical consequences
Hospitalization
97.0%
Severe reaction
2.5%
Death
0.2%
Life-threatening condition
0.2%
Have you experienced any negative side effects from this medication?
Orkambi: general information
Most common side effects (128)
Most commonly affected ages
0 - 9 years
19.9%
10 - 19 years
37.0%
20 - 29 years
23.4%
30 - 39 years
14.1%
40 - 49 years
5.1%
50 - 59 years
0.5%
Stay safe!
Get the latest drug safety information, personalized and delivered straight to your inbox